DOCSLIB.ORG

2015 ESC Guidelines for the Diagnosis and Management Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2015 ESC Guidelines for the Diagnosis and Management Of European Heart Journal Advance Access published August 29, 2015 European Heart Journal ESC GUIDELINES doi:10.1093/eurheartj/ehv318 2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) Downloaded from Authors/Task Force Members: Yehuda Adler* (Chairperson) (Israel), Philippe Charron* (Chairperson) (France), Massimo Imazio† (Italy), Luigi Badano (Italy), Gonzalo Baro´ n-Esquivias (Spain), Jan Bogaert (Belgium), Antonio Brucato http://eurheartj.oxfordjournals.org/ (Italy), Pascal Gueret (France), Karin Klingel (Germany), Christos Lionis (Greece), Bernhard Maisch (Germany), Bongani Mayosi (South Africa), Alain Pavie (France), Arsen D. Ristic´ (Serbia), Manel Sabate´ Tenas (Spain), Petar Seferovic (Serbia), Karl Swedberg (Sweden), and Witold Tomkowski (Poland) Document Reviewers: Stephan Achenbach (CPG Review Coordinator) (Germany), Stefan Agewall (CPG Review Coordinator) (Norway), Nawwar Al-Attar (UK), Juan Angel Ferrer (Spain), Michael Arad (Israel), Riccardo Asteggiano (Italy), He´ctor Bueno (Spain), Alida L. P. Caforio (Italy), Scipione Carerj (Italy), Claudio Ceconi (Italy), Arturo Evangelista (Spain), Frank Flachskampf (Sweden), George Giannakoulas (Greece), Stephan Gielen by guest on October 21, 2015 (Germany), Gilbert Habib (France), Philippe Kolh (Belgium), Ekaterini Lambrinou (Cyprus), Patrizio Lancellotti (Belgium), George Lazaros (Greece), Ales Linhart (Czech Republic), Philippe Meurin (France), Koen Nieman (The Netherlands), Massimo F. Piepoli (Italy), Susanna Price (UK), Jolien Roos-Hesselink (The Netherlands), * Corresponding authors: Yehuda Adler, Management, Sheba Medical Center, Tel Hashomer Hospital, City of Ramat-Gan, 5265601, Israel. Affiliated with Sackler Medical School, Tel Aviv University, Tel Aviv, Israel, Tel: +972 03 530 44 67, Fax: +972 03 530 5118, Email: [email protected]. Philippe Charron, Service de Cardiologie, Chu Ambroise Pare´, 9 av Charles de Gaulle, 92104 Boulogne Billancourt, France, Tel: +33149095543,Fax:+33142161364, Email: [email protected]. †Massimo Imazio: Coordinator, affiliation listed in the Appendix. ESC Committee for Practice Guidelines (CPG) and National Cardiac Societies document reviewers: listed in Appendix. a Representing the European Association for Cardio-Thoracic Surgery (EACTS). ESC entities having participated in the development of this document. ESC Associations: Acute Cardiovascular Care Association (ACCA), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), European Association of Car- diovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA). ESC Councils: Council for Cardiology Practice (CCP), Council on Cardiovascular Nursing and Allied Professions (CCNAP), Council on Cardiovascular Primary Care (CCPC). ESC Working Groups: Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Grown-up Congenital Heart Disease, Myocardial and Pericardial Diseases, Pulmonary Circulation and Right Ventricular Function, Valvular Heart Disease. The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC. Disclaimer: The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recom- mendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encour- aged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription. & The European Society of Cardiology 2015. All rights reserved. For permissions please email: [email protected]. Page 2 of 44 ESC Guidelines Franc¸ois Roubille (France), Frank Ruschitzka (Switzerland), Jaume Sagrista` Sauleda (Spain), Miguel Sousa-Uvaa (Portugal), Jens Uwe Voigt (Belgium), and Jose Luis Zamorano (Spain) The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines. ------------------------------------------------------------------------------------------------------------------------------------------------------ Keywords Guidelines † Aetiology † Constrictive pericarditis † Diagnosis † Myopericarditis † Pericardial effusion † Pericardiocentesis † Pericarditis † Pericardium † Prognosis † Tamponade † Therapy Table of Contents Abbreviations and acronyms . 3 4.1.6 Cardiac catheterization . 22 Preamble . 3 4.1.7 Multimodality imaging . 22 1. Introduction . 4 4.2 Proposal for a general diagnostic workup . 23 1.1 What is new in pericardial diseases? . 5 5. Specific aetiologies of pericardial syndromes . 24 Downloaded from 2. Epidemiology, aetiology and classification of pericardial 5.1 Viral pericarditis . 24 diseases . 5 5.1.2 Definition and clinical spectrum . 24 2.1 Epidemiology . 5 5.1.3 Pathogenesis . 25 2.2 Aetiology . 5 5.1.4 Diagnosis . 25 3. Pericardial syndromes . 5 5.1.5 Identification of viral nucleic acids . 26 http://eurheartj.oxfordjournals.org/ 3.1 Acute pericarditis . 5 5.1.6 Therapy . 26 3.1.1 Clinical management and therapy . 7 5.2 Bacterial pericarditis . 26 3.1.2 Prognosis . 9 5.2.1 Tuberculous pericarditis . 26 3.2 Incessant and chronic pericarditis . 9 5.2.1.1 Diagnosis . 27 3.3 Recurrent pericarditis . 9 5.2.1.2 Management . 27 3.3.1 Therapy . 9 5.2.2 Purulent pericarditis . 28 3.3.2 Prognosis . 12 5.2.2.1 Epidemiology . 28 3.4 Pericarditis associated with myocardial involvement 5.2.2.2 Diagnosis . 28 (myopericarditis) . 12 5.2.2.3 Management . 28 by guest on October 21, 2015 3.4.1 Definition and diagnosis . 12 5.3 Pericarditis in renal failure . 29 3.4.2 Management . 12 5.4 Pericardial involvement in systemic autoimmune and 3.4.3 Prognosis . 13 autoinflammatory diseases . 29 3.5 Pericardial effusion . 13 5.5 Post-cardiac injury syndromes . 30 3.5.1 Clinical presentation and diagnosis . 13 5.5.1 Definition and diagnosis . 30 3.5.2 Triage and management . 14 5.5.2 Management . 30 3.5.3 Therapy . 14 5.5.3 Prevention . 30 3.5.4 Prognosis and follow-up . 15 5.5.4 Prognosis . 30 3.6 Cardiac tamponade . 16 5.5.4.1 Post-myocardial infarction pericarditis . 30 3.7 Constrictive pericarditis . 17 5.5.4.2 Postoperative effusions . 31 3.7.1 Clinical presentation . 17 5.6 Traumatic pericardial effusion and haemopericardium . 31 3.7.2 Diagnosis . 17 5.7 Pericardial involvement in neoplastic disease . 32 3.7.3 Therapy . 17 5.8 Other forms of pericardial disease . 33 3.7.4 Specific forms . 18 5.8.1 Radiation pericarditis . 33 3.7.4.1 Transient constrictive pericarditis . 18 5.8.2 Chylopericardium . 34 3.7.4.2 Effusive-constrictive pericarditis . 19 5.8.3 Drug-related pericarditis and pericardial effusion . 34 3.7.4.3 Chronic constrictive pericarditis . 19 5.8.4 Pericardial effusion in metabolic and endocrine 4. Multimodality cardiovascular imaging and diagnostic work-up . 20 disorders . 34 4.1 Multimodality imaging . 20 5.8.5 Pericardial involvement in pulmonary arterial 4.1.1 Chest X-ray . 20 hypertension . 34 4.1.2 Echocardiography . 20 5.8.6 Pericardial cysts . 35 4.1.3 Computed tomography . 20 6. Age and gender issues in pericardial diseases . 35 4.1.4 Cardiac magnetic resonance . 20 6.1 Paediatric setting . 35 4.1.5 Nuclear medicine . 22 6.2 Pregnancy, lactation and reproductive issues . 35 ESC Guidelines Page 3 of 44 6.3 The elderly . 36 TRAPS tumour necrosis factor receptor-associated periodic 7. Interventional techniques and surgery . 36 syndrome 7.1 Pericardiocentesis and pericardial drainage . 36 TSH thyroid stimulating hormone 7.2 Pericardioscopy . 37 Tx treatment 7.3 Pericardial fluid analysis, pericardial and epicardial biopsy 37 uIFN-g unstimulated interferon-gamma 7.4 Intrapericardial treatment . 37 VEGF vascular endothelial growth factor
Load more

Recommended publications
  • J Wave Syndromes
    Review Article http://dx.doi.org/10.4070/kcj.2016.46.5.601 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Korean Circulation Journal J Wave Syndromes: History and Current Controversies Tong Liu, MD1, Jifeng Zheng, MD2, and Gan-Xin Yan, MD3,4 1Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 2Department of cardiology, The Second Hospital of Jiaxing, Jiaxing, China, 3Lankenau Institute for Medical Research and Lankenau Medical Center, Wynnewood, Pennsylvania, USA, 4The First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, China The concept of J wave syndromes was first proposed in 2004 by Yan et al for a spectrum of electrocardiographic (ECG) manifestations of prominent J waves that are associated with a potential to predispose affected individuals to ventricular fibrillation (VF). Although the concept of J wave syndromes is widely used and accepted, there has been tremendous debate over the definition of J wave, its ionic and cellular basis and arrhythmogenic mechanism. In this review article, we attempted to discuss the history from which the concept of J wave syndromes (JWS) is evolved and current controversies in JWS. (Korean Circ J 2016;46(5):601-609) KEY WORDS: Brugada syndrome; Sudden cardiac death; Ventricular fibrillation. Introduction History of J wave and J wave syndromes The concept of J wave syndromes was first proposed in 2004 The J wave is a positive deflection seen at the end of the QRS by Yan et al.1) for a spectrum of electrocardiographic (ECG) complex; it may stand as a distinct “delta” wave following the QRS, manifestations of prominent J waves that are associated with a or be partially buried inside the QRS as QRS notching or slurring.
    [Show full text]
  • Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment with Ankle Brachial Index in Adults the U.S
    Understanding Task Force Recommendations Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment with Ankle Brachial Index in Adults The U.S. Preventive Services Task Force (Task The Task Force reviewed the use of ABI to screen for Force) has issued a final recommendation statement PAD and to predict a person’s risk of heart attacks on Screening for Peripheral Artery Disease (PAD) and stroke. The final recommendation statement and Cardiovascular Disease (CVD) Risk Assessment summarizes what the Task Force learned about with Ankle Brachial Index (ABI) in Adults. the potential benefits and harms of this screening: There is not enough evidence to judge the benefits This final recommendation statement applies to and harms of using ABI for this purpose. adults who do not have signs or symptoms of PAD and who have not been diagnosed with PAD, CVD, This fact sheet explains the recommendation and severe chronic kidney disease, or diabetes. what it might mean for you. PAD is a disease in which fatty deposits called plaque build up in What is peripheral the arteries, especially those in the legs. Over time, the plaque can block the flow of blood to the legs often artery disease? leading to pain with walking. What is Cardiovascular disease affects the heart and blood vessels. It is caused by a build up of plaque in arteries that supply the heart, brain, and cardiovascular other parts of the body. When the build up is in the legs it is called disease? PAD. Heart attacks and strokes are other common types of CVD. Facts About CVD and PAD Cardiovascular disease is the leading killer of both men and women in the United States.
    [Show full text]
  • Cardiovascular Disease and Rehab
    EXERCISE AND CARDIOVASCULAR ! CARDIOVASCULAR DISEASE Exercise plays a significant role in the prevention and rehabilitation of cardiovascular diseases. High blood pressure, high cholesterol, diabetes and obesity can all be positively affected by an appropriate and regular exercise program which in turn benefits cardiovascular health. Cardiovascular disease can come in many forms including: Acute coronary syndromes (coronary artery disease), myocardial ischemia, myocardial infarction (MI), Peripheral artery disease and more. Exercise can improve cardiovascular endurance and can improve overall quality of life. If you have had a cardiac event and are ready to start an appropriate exercise plan, Cardiac Rehabilitation may be the best option for you. Please call 317-745-3580 (Danville Hospital campus), 317-718-2454 (YMCA Avon campus) or 317-456-9058 (Brownsburg Hospital campus) for more information. SAFETY PRECAUTIONS • Ask your healthcare team which activities are most appropriate for you. • If prescribed nitroglycerine, always carry it with you especially during exercise and take all other medications as prescribed. • Start slow and gradually progress. If active before event, fitness levels may be significantly lower – listen to your body. A longer cool down may reduce complications. • Stop exercising immediately if you experience chest pain, fatigue, or labored breathing. • Avoid exercising in extreme weather conditions. • Drink plenty of water before, during, and after exercise. • Wear a medical identification bracelet, necklace, or ID tag in case of emergency. • Wear proper fitting shoes and socks, and check feet after exercise. STANDARD GUIDELINES F – 3-5 days a week. Include low weight resistance training 2 days/week I – 40-80% of exercise capacity using the heart rate reserve (HRR) (220-age=HRmax; HRmax-HRrest = HRR) T – 20-60mins/session, may start with sessions of 5-15 mins if necessary T – Large rhythmic muscle group activities that are low impact (walking, swimming, biking) Get wellness tips to keep YOU healthy at HENDRICKS.ORG/SOCIAL..
    [Show full text]
  • Hemodynamic Assessment of Pneumopericardium by Echocardiography
    Extended Abstract Haemodynamics, deformation & ischaemic heart disease Hemodynamic assessment of pneumopericardium by echocardiography Matias Trbušić* KEYWORDS: pneumopericardium, cardiac tamponade, pericardiocentesis. CITATION: Cardiol Croat. 2017;12(4):124. | https://doi.org/10.15836/ccar2017.124 University Hospital Centre * “Sestre milosrdnice”, Zagreb, ADDRESS FOR CORRESPONDENCE: Matias Trbušić, Klinički bolnički centar Sestre milosrdnice, Vinogradska 29, Croatia HR-10000 Zagreb, Croatia. / Phone: +385-91-506-2986 / E-mail: [email protected] ORCID: Matias Trbušić, http://orcid.org/0000-0001-9428-454X Background: Pneumopericardium is a rare condition de- fined as a collection of air in the pericardial cavity. It is usually result of chest injuries, iatrogenic causes (bone marrow puncture, thoracic surgery, pericardiocentesis, endoscopic procedures), and infective agents causing pu- rulent gas - producing pericarditis.1,2 Case report: We represent a case of 82-year old female pa- tient with spontaneous pneumopericardium caused by malignant ulcer that created fistula between the pericar- dium and colon. She was admitted in very severe condi- tion with chest pain, severe respiratory distress, hypoten- sion, distended neck veins and tachyarrhythmia. High blood leukocyte, high C reactive protein levels and com- bined respiratory and metabolic acidosis were present. Electrocardiogram showed atrial fibrillation and diffuse micro voltage. Chest X ray and CT showed normal sized heart surrounded by air (halo sign) below the aortic arch, and large left pleural effusion. CT also revealed neoplastic process of the transverse colon infiltrating stomach and diaphragm. Due to intrapericardial spontaneous contrast echoes the image quality of 2-D echocardiography was poor making difficult to verify signs typical for tampon- ade such as early diastolic right ventricular collapse and early diastolic right atrial collapse (Figure 1).
    [Show full text]
  • Pneumopericardium and Tension Pneumopericardium After Closed-Chest Injury
    Thorax: first published as 10.1136/thx.32.1.91 on 1 February 1977. Downloaded from Thorax, 1977, 32, 91-97 Pneumopericardium and tension pneumopericardium after closed-chest injury S. WESTABY From Papworth Hospital, Cambridge Westaby, S. (1977). Thorax, 32, 91-97. Pneumopericardium and tension pneumopericardium after closed-chest injury. Three recent cases of pneumopericardium after closed-chest injury are described. The mechanism of pericardial inflation suspected in each was pleuropericardial laceration in the presence of an intrathoracic air leak. Deflation of the pericardium was achieved by underwater seal drainage of the right pleural cavity in the first patient, during thoracotomy for repair of tracheobronchial rupture-in the second, and by subxiphoid pericardiotomy in the last. Haemodynamic changes after escape of air from the pericardium of the second patient confirmed the existence of tension pneumopericardium and air tamponade. Pneumopericardium after a non-penetrating chest click. The right chest was resonant with decreased injury is rare. There are few previous reports of breath sounds. Precordial auscultation revealed a this lesion, and in the presence of additional in- loud splashing sound or 'bruit de moulin'. Chest jury its clinical importance remains poorly defined. radiographs demonstrated a large pneumopericar- This paper examines three recent cases in which dium and a 50% pneumothorax on the right, with operative deflation of the pericardium was per- no mediastinal shift. Needle aspiration of the http://thorax.bmj.com/ formed. In one case release of air resulted in pericardium was performed through the fourth marked haemodynamic changes leading to a left interspace and 40 ml of air with frothy blood diagnosis of tension pneumopericardium.
    [Show full text]
  • Cardiovascular Disease Session Guidelines
    Cardiovascular Disease Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars on the 3rd Wednesday of each month to address topics related to risk adjustment documentation and coding Next scheduled webinar: • Wednesday, February 28th • Topic: Respiratory Disease CNC does not accept responsibility or liability for any adverse outcome from this training for any reason including undetected inaccuracy, opinion, and analysis that might prove erroneous or amended, or the coder/physician’s misunderstanding or misapplication of topics. Application of the information in this training does not imply or guarantee claims payment. Agenda • Statistics • Amputation Status & Atherosclerosis • Angina Pectoris • Acute Myocardial Infarction • Specified Heart Arrhythmias • Congestive Heart Failure • Pulmonary Hypertension • Cardiomyopathy • Hypertensive Heart disease Statistics • Nearly 35 percent of Tarrant County and Dallas area deaths each year are attributed to cardiovascular disease. • About 610,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths • Heart disease is the leading cause of death for both men and women • Every year about 735,000 Americans have a heart attack. Of these, (approximately 70%) 525,000 are a first heart attack and (approximately 30%)210,000 happen in people who have already had a heart attack Amputations There are nearly 2 million people living with limb loss in the United States Approximately 185,000 amputations occur in the United States each
    [Show full text]
  • Inhalation of 1-1-Difluoroethane: a Rare Cause of Pneumopericardium
    Open Access Case Report DOI: 10.7759/cureus.3503 Inhalation of 1-1-difluoroethane: A Rare Cause of Pneumopericardium Erika L. Faircloth 1 , Jose Soriano 2 , Deep Phachu 1 1. Internal Medicine, University of Connecticut, Farmington, USA 2. Internal Medicine, Saint Francis Hosptial and Medical Center, Hartford, USA Corresponding author: Erika L. Faircloth, [email protected] Disclosures can be found in Additional Information at the end of the article Abstract We report a case of a 32-year-old man with a past medical history of ethanol use disorder who was brought in unresponsive after inhaling six to 10 cans of the computer cleaning product, Dust-Off. After regaining consciousness, he endorsed severe, pleuritic chest and anterior neck pain. Labs were notable for elevated cardiac enzymes, acute kidney injury, and his initial electrocardiogram (ECG) revealed a partial right bundle branch block with a prolonged corrected QT interval (QTc). On chest X-ray as well as chest computed tomography, the patient was found to have pneumomediastinum, pneumopericardium, and subcutaneous emphysema. The patient’s course was uneventful and he was discharged home two days later after extensive substance abuse cessation counseling. Intentionally inhaling toxic substances, also known as “huffing,” is a dangerous new trend with significant consequences that clinicians need to be aware of and suspect in young patients presenting with chest pain. We present a rare case of pneumopericardium induced by inhalation of Dust-Off (1-1-difluoroethane). Categories: Cardiac/Thoracic/Vascular Surgery, Cardiology, Internal Medicine Keywords: 1-1-difluoroethane, fluorinated hydrocarbon, cardiology, pneumopericardium, pneumomediastinum, inhalant abuse Introduction 1-1-difluoroethane is a colorless, odorless gas [1].
    [Show full text]
  • What Works Fact Sheet: Cardiovascular Disease Prevention
    www.thecommunityguide.org Cardiovascular Disease Prevention and Control Evidence-Based Interventions for Your Community ardiovascular disease refers to several types of conditions that affect the heart and blood vessels. Cardiovascular diseases, including heart disease and stroke, account for one-third of all U.S. deaths and contribute an C 1, 2 estimated $315 billion annually in healthcare costs and lost productivity. Many cardiovascular disease risk factors, such as high blood pressure, high cholesterol, excess weight, poor diet, smoking and diabetes, can be prevented or treated through behavior change and appropriate medication.3 This brochure is designed to help public health program planners, community advocates, educators, primary care providers and policymakers find proven intervention strategies—including programs, services and policies—to plan evidence-based care that has been proven to reduce patients’ risk for cardiovascular disease. It can help decision makers in both public and private sectors make choices about what intervention strategies are best for their communities. This brochure summarizes information in The Guide to Community Preventive Services (The Community Guide), an essential resource for people who want to know what works in public health. Use the information in this brochure to help select from the following intervention strategies you can use in your community and healthcare organizations: z Introduce clinical decision-support systems within healthcare systems to implement clinical guidelines at the point of care. z Reduce out-of-pocket costs for medications to control high blood pressure and high cholesterol in patients. z Incorporate multidisciplinary team-based care within healthcare systems, including the patient, the primary care provider, and other professionals such as nurses, pharmacists, dietitians, social workers and community health workers, in order to improve blood pressure control.
    [Show full text]
  • Types of Cardiovascular Disease
    18-19 Types of CVD CYAN MAGENTA YELLOW BLACK Stroke Strokes are caused by disruption of the blood supply to the brain. This may result from either blockage (ischaemic 1 Types of cardiovascular stroke) or rupture of a blood vessel (haemorrhagic stroke). 2 265 824 Risk factors High blood pressure, atrial fibrillation (a heart Coronary heart disease kills disease Coronary heart disease rhythm disorder), high blood cholesterol, tobacco use, “All the knowledge I possess everyone else Disease of the blood vessels more than can acquire, but my heart is all my own.” unhealthy diet, physical inactivity, diabetes, 7 million people Johann Wolfgang von Goethe Deaths from cardiovascular diseases (CVD) supplying the heart muscle. and advancing age. each year, and The Sorrows of Young Werther 1774 Number of deaths globally per year Major risk factors High blood pressure, strokes kill from different types of CVD, high blood cholesterol, tobacco use, nearly 6 million. The human heart is only the size by age 1 868 339 unhealthy diet, physical inactivity, Most of these Highest numbers shown of a fist, but it is the strongest diabetes, advancing age, inherited deaths are in muscle in the human body. 2002 developing (genetic) disposition. countries. The heart starts to beat in the coronary heart disease Other risk factors Poverty, low educational uterus long before birth, usually stroke status, poor mental health (depression), by 21 to 28 days after conception. inflammation and blood clotting disorders. The average heart beats about other cardiovascular diseases Aortic aneurysm and 100 000 times daily or about two hypertensive heart disease Rheumatic heart disease dissection and a half billion times over a Dilatation and rupture inflammatory heart disease Damage to the heart muscle and heart 70 year lifetime.
    [Show full text]
  • Cardiovascular Disease: a Costly Burden for America. Projections
    CARDIOVASCULAR DISEASE: A COSTLY BURDEN FOR AMERICA PROJECTIONS THROUGH 2035 CARDIOVASCULAR DISEASE: A COSTLY BURDEN FOR AMERICA — PROJECTIONS THROUGH 2035 american heart association CVD Burden Report CVD Burden association heart american table of contents INTRODUCTION ...................................................................................5 ABOUT THIS STUDY ................................................................................................... 6 WHAT IS CVD? ......................................................................................................... 6 Atrial Fibrillation Congestive Heart Failure Coronary Heart Disease High Blood Pressure Stroke PROJECTIONS: PREVALENCE OF CVD .............................................................7 Latest Projections Age, Race, Sex – Differences That Matter PROJECTIONS: COSTS OF CVD ................................................................. 8-11 The Cost Generators: Aging Baby Boomers Medical Costs Breakdown Direct Costs + Indirect Costs RECOMMENDATIONS .............................................................................13-14 Research Prevention Affordable Health Care 3 CARDIOVASCULAR DISEASE: A COSTLY BURDEN FOR AMERICA — PROJECTIONS THROUGH 2035 american heart association CVD Burden Report CVD Burden association heart american Introduction Cardiovascular disease (CVD) has been the leading killer In addition, CVD has become our nation’s costliest chronic of Americans for decades. In years past, a heart attack disease. In 2014, stroke and heart
    [Show full text]
  • Isolated Pneumopericardium After Penetrating Chest Injury
    CASE REPORT East J Med 24(4): 558-559, 2019 DOI: 10.5505/ejm.2019.25582 Isolated Pneumopericardium After Penetrating Chest Injury Hasan Ekim1*, Meral Ekim2 1Bozok University Faculty of Medicine Department of Cardiovascular Surgery, Yozgat 2 Bozok University Faculty of Health Sciences, Department of Emergency Aid and Disaster Management, Yozgat ABSTRACT Pneumopericardium is defined as the presence of air or gas in the pericardial sac. Its course is stable unless tension pneumopericardium develops. However, even patients with asymptomatic pneumopericardium should be carefully monitored due to risk of tension pneumopericardium. We presented a 24-year-old male victim with stab wound complicated with isolated pneumopericardium. Pneumopericardium was accidentally encountered by plain chest radiograph. It was spontaneously resolved without pericardiocentesis or pericardial window. Key Words: Pneumopericardium, Stab Wound, Isolated Introduction Discussion Pneumopericardium is defined as the presence of air Pneumopericardium is a rare complication of blunt or or gas in the pericardial sac (1). It is commonly seen penetrating thoracic trauma and may also occur in neonates on mechanical ventilation and in victims iatrogenically (3). In addition, pericardial infections sustaining blunt thoracic trauma (1). However, may also lead to pneumopericardium (4). Lee et al (5) iatrogenic lesions such as barotrauma, endoscopic and reported that the swinging movement of the drainage surgical interventions may also lead to bottle may allow air in the bottom of the bottle to pneumopericardium. (2). A pneumopericardium due enter the chest tube and then into the pericardial to penetrating thoracic trauma is also rare (1). We space leading to pneumopericardium. Therefore, care presented an interesting case of stab wound should be taken when transporting patients complicated with isolated pneumopericardium.
    [Show full text]
  • Huge Pneumopericardium with Irreversible Dilatation of the Pericardial Sac After Cardiac Tamponade
    Kardiologia Polska 2014; 72, 10: 985; DOI: 10.5603/KP.2014.0196 ISSN 0022–9032 STUDIUM PRZYPADKU / CLINICAL VIGNETTE Huge pneumopericardium with irreversible dilatation of the pericardial sac after cardiac tamponade Rozległa odma osierdziowa z nieodwracalnym poszerzeniem jamy osierdzia po odbarczeniu tamponady Iga Tomaszewska1, Sebastian Stefaniak2, Piotr Bręborowicz1, Tatiana Mularek-Kubzdela3, Marek Jemielity3 1Poznan University of Medical Sciences, Poznan, Poland 2Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland 31st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland An 86-year-old female patient was referred to the Department of Cardiology in order to drain a pericardial effusion (Fig. 1). The diagnosis had been made in a suburban general hospital by echocardiography confirmed by computed tomography (CT) (Fig. 2). The maximum thickness of fluid layer was 63 mm. On admission, our patient reported significant peripheral oedema and difficulty in swallowing associated with periodic vomiting for two years. For the past two months, she had suffered from breathlessness, even after slight effort or eating, which intensified in the evening. Those symptoms progres- sively worsened. Only oedema of the limbs decreased after pharmacological treatment for heart failure. On admission, the jugular veins were distended up to 1.5 cm. The manubrium and sternal angle were protuberant. The apex beat was diffuse, hyperdynamic and displaced laterally and inferiorly. Cardiac rhythm was irregular, average heart rate was 70/min and blood pressure was 167/52 mm Hg. Heart sounds were loud and muffled with a systolic-diastolic murmur over the aortic valve. The liver was enlarged to 4 cm below the costal arch.
    [Show full text]